BIBLIOGRAPHIC RECORD
Utility of Imaging-Based Biomarkers for Glutamate-Targeted Drug Development in Psychotic Disorders
This record contains bibliographic metadata. Open the linked source to check the work; the record does not include its full text.
- Recorded authors
- Daniel C. Javitt; Cameron S. Carter; John Harrison Krystal; Joshua T. Kantrowitz; Ragy R. Girgis; Lawrence S. Kegeles; John Daniel Ragland; Richard J. Maddock; Tyler A. Lesh; Costin Tanase; Philip Robert Corlett; Douglas L. Rothman; Graeme F. Mason; Maolin Qiu; James A. Robinson; William Z. Potter; Marlene Carlson; Melanie M. Wall; Tse-Hwei J. Choo; Jack Grinband; Jeffrey Alan Lieberman
- Source of metadata
- OpenAlex
- Year recorded
- 2017
Public identifiers and source
Open the source recordReference
Daniel C. Javitt; Cameron S. Carter; John Harrison Krystal; Joshua T. Kantrowitz; Ragy R. Girgis; Lawrence S. Kegeles; John Daniel Ragland; Richard J. Maddock; Tyler A. Lesh; Costin Tanase; Philip Robert Corlett; Douglas L. Rothman; Graeme F. Mason; Maolin Qiu; James A. Robinson; William Z. Potter; Marlene Carlson; Melanie M. Wall; Tse-Hwei J. Choo; Jack Grinband; Jeffrey Alan Lieberman. (2017). Utility of Imaging-Based Biomarkers for Glutamate-Targeted Drug Development in Psychotic Disorders. https://openalex.org/W2770367203
Reference assembled from the available metadata. Check and cite the original publication before reusing a claim.
Permanent record URL: https://brain.psiconautica.org/en/documentos/d-d9f72b8d1397fffcb4c09ad97347a13c/